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Antimicrobial resistance (AMR) has become a global concern as many bacterial 
species have developed resistance to commonly prescribed antibiotics, making them 
ineffective to treatments. One type of antibiotics, gallium(III) compounds, stands out 
as possible candidates due to their unique “Trojan horse” mechanism to tackle 
bacterial growth, by substituting iron(III) in the metabolic cycles of bacteria. In this 
study, we tested three polysaccharides (carboxymethyl cellulose CMC, alginate, and 
pectin) as binding and delivery agent for gallium on three bacteria (P. aeruginosa, E. 
coli and S. aureus) with a potential bioresponsive delivery mode. Two types of analysis 
on bacterial growth (Minimum Inhibitory Concentrations (MIC) and Minimum 
Bactericidal Concentrations (MBC)) were carried out while Iron(III) loaded 
polysaccharide samples were also tested for comparison. Results suggested that 
gallium showed an improved inhibitory activity on bacterial growth, in particular 
gallium(III)-loaded carboxymethyl cellulose (Ga-CMC) sample showing inhibiting 
effect on growth for all three tested bacteria. At the MIC for all three bacteria, Ga-CMC 
showed no cytotoxicity effect on Human Dermal Neonatal Fibroblasts (HDNF). 
Therefore, these bioresponsive gallium(III) polysaccharide compounds show 
significant potential to be developed as the next generation antibacterial agents with 








The increasing problem of antibiotic resistance has generated significant concerns 
over the ability to treat infectious disease in humans. In 2016, a high-level meeting on 
Antimicrobial Resistance (AMR) was held at the United Nations HQ, New York to 
finalise a global plan combating this world-wide crisis1. Notably, one research strategy 
tackling AMR is the search for new types of antimicrobial agents from naturally-
occurring, environmentally friendly materials2. For example, allicin from garlic3 and 
cinnamaldehyde from the leaves of the cinnamon plant4, as well as metallic 
compounds (e.g. Fe- and Pt-peptides and maltolato complexes), long purported to 
deliver an antimicrobial effect5, 6.  
Recently, soluble gallium compounds (Ga3+) have been used in several 
biomedical applications including the treatments of bone-associated cancers7, 8 and 
infectious diseases9, 10. The antibacterial action of Ga3+ is strongly linked to sharing 
similar properties with Fe3+ ions (including electronic configuration, atomic radius and 
coordination chemistry). The survival of many microorganisms relies upon the 
availability of iron, particularly Fe3+, which takes part in numerous redox driven 
biological processes such as respiration and DNA synthesis, and in particular their 
activity as iron siderophore analogues11. The electron transition between a 3+ state to 
2+ (and vice versa) only requires low energy for Fe systems, and therefore these 
crucial processes readily occur.  However, such redox transition requires much higher 
energy for Ga (Ga3+ → Ga+ while Ga2+ has not yet been identified) and substitution of 
Fe3+ with Ga3+ in protein binding sites disrupt these vital processes12. Given that this 
mode of antibacterial action is different from those of conventional, organic antibiotics, 
gallium could prove to be less vulnerable to resistance mechanisms such as reduced 
uptake due to restricted permeability of bacterial cell membranes13. Since the use of 
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gallium as a drug product (gallium-67 citrate) has already been approved by the FDA9, 
Ga-bound natural products could be considered to be safe for trial use as an 
antimicrobial agents. 
 Many gallium-based materials reported for research on antibacterial activity are 
water-soluble species such as gallium nitrate14-16 and other organometallic Ga-
complexes (e.g. Ga-maltolate17,18, Ga-EDTA19, Ga-desferrioxamine20, Ga-
porphyrins21-24 and Ga-quinolone25). Release of these water-soluble gallium 
compounds can be difficult to control. This causes problematic applications as dry 
environment is likely to be required, while water is difficult to avoid in many biological 
systems. A feasible controlled release platform will greatly improve the usability of 
some of these antibacterials. To address this, gallium-based bioglass materials have 
been developed and shown such a controlled release by varying the composition of 
the glass, in particular the calcium content26-30. However, such a control is still strongly 
linked to the solubility of the material, regardless of whether the bacteria are present 
in the media or not. To achieve a controlled release, gallium species have been 
incorporated onto a degradable polymer substrate. Ma et al. have demonstrated the 
preparation of poly(ether urethane), or PEU, blended with Ga-protoporphyrin or 
mesoprotoporphyrin complex11. This material have shown antibacterial activity 
towards both Staphylococcus epidermidis (Gram-positive bacterial species) and 
Pseudomonas aeruginosa (Gram-negative bacterial species), but there is limited 
information on Ga release due to non-bacterial solvation or degradation. Valappil et 
al. have reported the use of carbonxymethyl cellulose (CMC) as the polymer substrate 
with the gallium species (Ga3+ ions) directly bound onto the carboxylic acid groups on 
the polymer structure31. Since this crosslinked polymer is not water-soluble, the 
release of Ga was theorised to be a consequence triggered by the digestive action of 
5 
 
viable P. aeruginosa cells in the test matrix, initiating bioresponsive delivery of gallium. 
The antibacterial activity of a related material gallium alginate (Ga-Alg) has also been 
reported when used in conjunction with bioglass32. 
 In our study, a family of bioresponsive antibacterial materials are prepared 
based on gallium and iron(III) crosslinked polysaccharide materials (carboxymethyl 
cellulose, pectin, alginate). These polysaccharides were chosen because of the 
carboxylic acid groups on their polymer backbone, allowing the co-ordination of Ga3+ 
and Fe3+ ions onto the polymers. Three representative bacterial species were used as 
test organisms, namely, Escherichia coli (NCTC 8196), Staphylococcus aureus 
(NCTC 6571) and Pseudomonas aeruginosa (NCIMB 10548). All three species are 
regarded as potentially significant species capable of causing infectious diseases and 
as a threat to human health due to their high rate of resistance to contemporary 
antimicrobials. Enzymatic degradation profiles and cytotoxicity of the metal-loaded 
polysaccharides were also examined to provide essential information about these 
materials for further development of clinical applications.   
 
2. Materials and methods 
2.1 Materials 
Gallium nitrate (Ga(NO3)3.H2O, 99.9%) was supplied by Alfa Aesar, UK. Ferric nitrate 
(Fe(NO3)3.9H2O, 99%), carboxymethyl cellulose (CMC, 250 kDa, D.S.=0.9), pectin 
(from citrus peel, galacturonic acid ≥74.0 %), cellulase from Aspergillus niger (>0.8 
U/mg), pectinase from Aspergillus niger (>1.0 U/mg), alginate lyase (≥10,000 U/g), 
Phosphate-buffered saline (PBS) and resazurin were all purchased from Sigma 
Aldrich, UK. Alginic acid sodium salt was purchased from Fisher Scientific UK. Sodium 
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acetate buffer (0.2 M, pH 7) was prepared from sodium hydroxide (CertiFied AR grade, 
Fisher Scientific, UK) and glacial acetic acid (Sigma-Aldrich, UK). Human Dermal 
Neonatal Fibroblasts (HDNFs) were purchased from the Coriell Institute for Medical 
Research, Camden, New Jersey, USA, Dulbecco's Modified Eagle Medium (DMEM) 
high glucose was supplied by Lonza, foetal bovine serum (FBS), 
penicillin/streptomycin and TrypLE Express were purchased from Gibco. Dimethyl 
sulfoxide (DMSO, laboratory grade) was purchased from Fisher Scientific, UK. All 
water used was deionised water. All chemicals and materials were used as received 
without further purification. All microbiological media were purchased from Fisher 
Scientific (UK).  
 
2.2 Preparation of Ga3+ and Fe3+ polysaccharides 
The preparation procedure of Ga3+-CMC has been published previously31. This 
method was adapted for the preparation of all Ga3+ and Fe3+ polysaccharide materials 
used in this work. In general, 1.0 g of the polysaccharide source (carboxymethyl 
cellulose CMC, pectin, and alginate) was dissolved in 150 mL of deionised water in a 
250 mL conical flask under magnetic stirring. A 0.1 M solution of Ga(NO3)3 or Fe(NO3)3 
was added drop-wisely to the polysaccharide solution causing a gelatine precipitate to 
form. The amount of Ga3+ and Fe3+ added was calculated from the maximum ion 
exchange capacity of the polysaccharides (based on the amount of carboxylic acid 
group). To ensure an exchange close to 100%, an excess of metal (50%) was added. 
The gel was stirred overnight with the flask sealed with parafilm to minimise 
evaporation. Finally the gel was recovered by filtration and allowed to dry in air to form 
a hard solid. The dried solid was then ground to a powder for antibacterial tests and 




2.3 Characterization of Ga3+ and Fe3+ polysaccharides 
Thermogravimetric analysis (TGA) was used to determine the inorganic content of the 
samples. A TA Instrument STD600 thermobalance was used for this purpose. In a 
typical experiment, a ca. 5 mg sample was heated up in flowing air (100 mL min-1) at 
a heating rate of 5°C min-1 to 700°C where the sample was held isothermal for 60 min. 
The residual weight was due to inorganic oxides, Ga2O3 or Fe2O3. Details of 
calculation can be found in Supplementary Information. The surface morphology and 
the metal distribution of samples were studied by a scanning electron microscopy 
(SEM) and Energy Dispersive X-ray (EDX) spectroscopy. Energy-dispersive X-ray 
(EDX) spectroscopy was performed in conjunction with scanning electron microscopy 
(SEM) on a Philips XL30 ESEM with an attached Oxford Instruments x-act EDX 
detector. EDX spectroscopy was used to determine the elemental composition of the 
materials, whilst the micrographs taken provide a visual representation of the 
morphology of the products. About 0.5 mg of each material was placed on carbon 
tape; the materials were insufficiently conductive and gold sputtering was required to 
enhance the conductivity prior to imaging. All micrographs and EDX spectra were 
recorded using a beam current of 20 kV. A Thermo Scientific Nicolet iS5 spectrometer 
was used for FTIR spectroscopy with 16 scans for each sample at a resolution of 4 
cm-1. 
 
2.4 Enzymatic degradation profile 
Degradation profile of the Fe3+ polysaccharides materials was studied using the 
corresponding enzyme (e.g. pectinase for Fe3+ pectin). Iron(III) polysaccharides were 
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chosen for the study due to the colour (visible light absorbance) allowing 
spectrophotometric measurement. In a typical experiment, 20 mg of Fe3+ 
polysaccharide powder was suspended in sodium acetate buffer solution (5 mL, 0.2 
M, pH = 7). A neutral pH was chosen to avoid acid/base-initiated digestion of the 
carbohydrate material. Enzyme (1 mg/mL) was then added and the suspension was 
incubated at 37°C. After a set time interval, the sample was cooled down using an ice 
bath to slow down the enzymatic action.  The solution was then filtered and the 
supernatant was collected. The absorbance of supernatant at 450 nm was recorded 
using a Shimadzu UV-mini 1240 spectrometer. The % degradation values were 
calculated against that from a sample fully digested using conc. HCl. In general, at a 
certain time point, % degradation = (At / Af)×100%, where At was the absorbance of 
the supernatant at time t while Af was the absorbance of the fully digested sample. All 
experiments were triplicated and the absorbance data presented was the average 
values of the three experiments. Sodium acetate buffer was chosen to avoid 
precipitation of iron(III) salts (e.g. iron(III) phosphate from PBS or iron(III) carbonate 
from sodium carbonate buffer). 
 
2.5 Evaluation of cell viability  
2.5.1 Culture of Human Dermal Neonatal Fibroblasts 
Human Dermal Neonatal Fibroblasts (HDNFs) were seeded at a density of 1.0 × 104 
cells/cm2 and cultured in DMEM high glucose, supplemented with 10% (v/v) FBS and 
1% penicillin/streptomycin, at 37 °C and 5% CO2. Culture medium was replaced every 
3 days until 80% confluence was reached. Then, the culture medium was removed, 
the cells were washed twice in sterile PBS and incubated for 5 minutes in TrypLE 
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Express. In order to neutralize trypsin, 5 mL of culture medium were added. After 
counting, the cells (passage 9) were seeded in 96 well plates (1.0 × 104 cells/well) and 
incubated under the same conditions for 24h.  
2.5.2. Preparation of liquid extracts 
Extracts from the compounds under study were prepared based on ISO standard 
ISO10993-5 for cytotoxicity evaluation of medical devices. DMEM high glucose, 
supplemented with 10% (v/v) FBS and 1% penicillin/streptomycin, which was the 
medium used for cell culture, was employed as the extraction vehicle in this study. 
Test materials were mixed with the extraction vehicle at 50 mg/mL and incubated for 
24 hours at 37 °C. Then, the mixtures were centrifuged for 10 minutes at 14000 rpm 
to remove the non dissolved fraction, and the supernatant was recovered. A ten-fold 
serial dilution was performed in order to obtain solutions up to 1/1000 of the 
concentration of the original extract. The possible effects of the extraction procedure 
on the extraction vehicle, and subsequently on cell viability, were assessed by 
preparing a control group in which culture medium with no test sample was subjected 
to all the extraction conditions. 
2.5.3 Evaluation of cell viability after exposure 
Possible cytotoxic effects caused by the developed formulations were extrapolated 
from cell viability testing in HDNFs, after 24 hours of exposure to the extracts and 
respective dilutions (ISO10993-5). HDNFs seeded in 96 microplates (1.0 × 104 
cells/well) were incubated at 37 °C, 5% CO2 for 24 hours, after which, culture medium 
was replaced with the extracts and respective dilutions. A negative control, which was 
used to normalize the results, was prepared by incubating the cells with their regular 
culture medium, and a positive control by incubating the cell with 20% DMSO in culture 
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medium. A control group for the extraction procedure was also prepared. In that group, 
cells were incubated with culture medium that did not contain any test sample but was 
subjected to all the extraction conditions. After 24 hours of incubation under controlled 
conditions, the extracts and medium from the controls were removed and cell viability 
was measured using a resazurin assay. Briefly, 100 μL of a solution of 10% resazurin 
(0.1mg/mL in PBS) were added to each well and incubated for 3 hours at 37°C. After 
incubation, 100 μL were collected and the fluorescence was read at 530 nm excitation 
and 590 nm emission. The percentage of cell viability in each condition was obtained 
after normalization to the negative control. Three independent replicates were 
performed, in which all the conditions were tested in triplicate. The results are 
expressed as the average ± standard deviation of the independent experiments. 
Statistical significance of the results was analyzed using a One Way ANOVA test, 
followed, by a Tukey's multiple comparisons test. 
 
2.6 Minimum inhibitory and minimum bactericidal concentrations (MIC and 
MBC) 
2.6.1 Culture of bacteria 
Bacterial cultures were obtained from the in-house culture collection of the School of 
Pharmacy & Biomolecular Sciences at the University of Brighton. The cultures were 
streaked on nutrient agar (Oxoid, UK) and aerobically incubated for 18 hours. After 
that time, for each test species, three morphologically correct colonies were aseptically 
transferred to 10 mL Isosensitest broth (Oxoid, UK), and aerobically incubated for 18 
hours in an orbital shaker (Stuart Scientific, UK). 
2.6.2 Determination of MIC and MBC 
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These experiments were conducted according to the macrodilution protocol of 
Andrews33. Briefly, a solution of each of the test compounds was constituted using 
Isosensitest broth (Oxoid, UK), and serially diluted two-fold by pipetting to obtain a 
concentration dose range. To each test tube, an aliquot (approx. 10 µL) of overnight 
culture of each test bacterium was added to give a final concentration of approximately 
1 × 106 CFU/mL. A positive growth control of bacteria in the Isosensitest broth plus a 
negative control of Isosensitest broth only was also set up for each test. Each test was 
performed in triplicate, and the tubes were incubated at 37°C for 20 hours. 
After this period, the Minimum Inhibitory Concentration (MIC) was determined 
by macroscopic observation of the tubes. Those tubes without visible growth were 
recorded as containing sufficient concentration of the test compound to inhibit growth, 
and the tube with the lowest concentration of the test compound registering no visible 
growth was recorded as the MIC value. From each of the tubes that demonstrated no 
macroscopic growth, 200 µL was plated on to Isosensitest agar (each tube plated in 
triplicate, and each dilution series plated in triplicate), in order to determine the 
Minimum Bactericidal Concentration (MBC). These plates were incubated at 37°C and 
observed for growth at 24, 48 and 72 hours. The plates with the lowest concentration 
of test compound to yield no bacterial colonies were recorded as the MBC values. For 
growth inhibition assays in anaerobic environment, the same experiment was carried 
out in a Whitely A35 Anaerobic Workstation (Don Whitely Scientific) using anaerobic 
gas mixture (80% N2, 10% H2, 10% CO2; supplied by BOC). For this, E coli (P4 wild-
type strain) was used for both anaerobic and aerobic growth experiments.  
 
3. Results and discussion 
3.1 Characterization of Ga3+ and Fe3+ polysaccharides 
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All carboxymethyl cellulose (CMC), pectin and alginate formed crosslinked gels with 
Ga3+ or Fe3+ solution. The structure of Ga3+ bound CMC, pectin and alginate are 
proposed in Figure S1. From Table 1, TGA analysis revealed the metal content of the 
samples varied from 1.10 – 1.62 mmol/g (or 6.6 – 10.6 % w/w) which is close to 
saturation based on the number of carboxylic acid groups on the polymer. The EDX 
elemental mapping on the SEM micrograms (Figure 1) reveals homogeneous 
distribution of both Ga3+ and Fe3+ within the samples. This is consistent with the 
literature31. 
 
Table 1. Metal content of Ga3+- and Fe3+-polysaccharide samples from TGA.  
 
Sample Metal content [mmol/g] Metal content [% w/w] 
Ga3+-CMC 1.52 10.6 
Ga3+-alginate 1.10 7.7 
Ga3+-pectin 1.35 9.4 
Fe3+-CMC 1.19 6.6 
Fe3+-alginate 1.62 9.0 







Figure 1. Scanning electron micrographs (SEM) and corresponding EDX mapping for 
(a) Ga-CMC, (b) Fe-CMC, (c) Ga-pectin, (d) Fe-pectin, (e) Ga-alginate, (f) Fe-alginate 
showing homogeneous distribution of metal ions within the samples. 
 
The FTIR spectra of CMC samples show typical stretching signal for (C=O) at 
~1730 cm-1 and (C-O) at ~1590 cm-1 corresponding to the carboxylic acid groups on 
the polysaccharide backbone (Figure 2). The remaining significant peaks can be 
assigned as follows: 3310 cm-1 for –OH stretching (OH), 2920 cm-1 for –CH stretching 
(C-H), 1410 cm-1 for –CH2 symmetrical bending (CH2) or C-OH bending (C-OH), 
1310 cm-1 for –CH2 wagging (CH2) and 1030 cm-1 for C-O-C stretching modes (C-
O-C). All investigated products retain most of the spectroscopic features associated 
with the original CMC polymeric network suggesting that the CMC structure has been 
unchanged upon the ion-exchanging process. The FTIR spectra of alginate and pectin 
samples (Figure 2b and c) show similar features, in particular the carboxylic acid 
(a) Ga-CMC (b) Fe-CMC
(c) Ga-pectin (d) Fe-pectin
(e) Ga-alginate (f) Fe-alginate
50 μm 50 μm
50 μm 50 μm
50 μm 50 μm
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groups at ~1730 and ~1600 cm-1. In terms of their structure, three model 
polysaccharides are highly compatible.  
 
Figure 2. FTIR spectra for metal loaded polysaccharide samples (a) 
carboxymethylcellulose; (b) alginate and (c) pectin. The as-received Na+ 
polysaccharides are indicated with black lines (i). Ga3+ loaded samples are indicated 


































































main features of these polymers are highlighted at a region between 1580 – 1750 cm-
1, where the bands associated with the carboxylate groups are located. 
 
3.2 Enzymatic degradation profile 
To develop bioresponsive, biodegradable platforms for controlled release and delivery 
of bioactive agents, the release profile and kinetics of the bioactives due to 
biodegradation of material is essential. In order to probe the metal ion release profile 
from Fe3+ polysaccharides under enzymatic action, a spectrophotometric experiment 
was setup. It is not straight forward to probe the release of Ga3+ due to its colourless 
nature. Study on Fe3+ samples instead could provide some information for the 
degradation profile of Ga3+ release from the polysaccharide samples because of the 
similarity of their structures. Figure 3 showed the degradation profile of Fe-CMC and 
Fe-pectin in presence of cellulase (hydrolyzing of the 1,4-β-D-glycosidic linkages in 
cellulose)34 and pectinase (hydrolyzing (1→4)-α-D-galacturonan methyl ester and α-
1,4-glycosidic linkages)35. Alginate lyase (hydrolyzing the (1-4)-β-D-mannuronate 
linkages)36 was shown to have low activity towards Fe-alginate, only < 15% 
degradation after 4 days, possibly due to the strong crosslinking from Fe3+ ions. 
Degradation of Fe-CMC (Figure 3a) showed a linear profile over 24 h and reached 
around 80% degradation. In contrast, an almost complete degradation for Fe-pectin 
was achieved in 8 h (Figure 3b). Although the enzyme concentration used in both 
experiment was roughly the same (1 mg/mL or 1 U/mL), it is difficult to directly compare 




The non-enzymatic degradation profiles of Fe-CMC and Fe-pectin were also 
shown in Figure 3. In absence of cellulase, Fe-CMC did not release any Fe3+ ions 
while Fe-pectin showed some release (up to ~15%). This is due to possible ion 
exchange with Na+ ions from buffer. No such ion exchange was observed from Fe-
CMC if the crosslinking due to Fe3+ is stronger. This could also contribute to the slower 
degradation rate under an enzymatic action. Results from this set of experiments 
indicate that Fe-CMC could be more suitable for long-term release of Fe3+ than Fe-




Figure 3. Degradation profile for (a) Fe3+-CMC in 1mg/mL cellulase and (b) Fe3+-pectin 
in 1 mg/mL pectinase. The dashed lines are control experiments in buffer with no 




























3.3 Cell viability after exposure to the compounds 
In this study, the cell viability of HDNFs after exposure to extracts of both metal loaded 
and the base materials was used as an indicator of the potential cytotoxic effects of 
the developed compounds. The Resazurin assay chosen for this study allows 
evaluation of the metabolic activity of cells as an indicator of cell viability and it is widely 
used to extrapolate the toxicity of natural polymer materials (e.g. silk and alginate). 
The three chosen polysaccharide materials (pectin, Na-CMC and alginate sodium salt) 
have been generally accepted as safe for human administration. Alginate is generally 
regarded as having good biocompatibility, evidenced by over 30 years of use as a 
hydrogel material for cell growth, tissue engineering38 and wound healing39. 
Carboxymethyl cellulose is commonly used in food and pharmaceutical industries40, 
and has also been exploited for preparing hydrogels for tissue engineering41 while 
pectin showed a wide range of biomedical applications42  However, cytotoxic effects 
have been reported for gallium, depending on both the gallium moiety and the anionic 
component43 and iron, in a tissue and dose dependent manner44. Therefore, it was 
essential to investigate if the inclusion of metal components in the formulations 
conferred these compounds a cytotoxic character, by analysing the effect of their 
extracts on cell viability. Figure 4 shows that the extraction procedure had no 
interference with the ability of the culture medium to provide the adequate conditions 
for cell growth. Compared to the negative control, the base polysaccharide materials 
caused a reduction in cell viability that ranged from approximately 60% in the case of 
Na-CMC (P≤ 0.0001), 42% for pectin (P≤ 0.05) and 31% for Na-alginate. However, no 
statistical significance was found between Na-alginate and the negative control (P≥ 
0.05), and since the obtained viability is around 70%, this compound showed no 
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cytotoxic effects towards HDNFs. Ga-based compounds showed a similar pattern. Cell 
viability downturned around 65% in cells incubated with Ga-pectin extracts (P≤ 
0.0001), 50% with Ga-alginate (P≤ 0.001) and 34% with Ga-CMC. Again, Ga-CMC 
showed no statistical difference in comparison with the control (P≥ 0.05), and the 
viability value bordering 70% indicates no cytotoxic effects. Fe-based samples 
displayed a very different outcome. Whereas no viability decrease was detected in the 
samples incubated with Fe-CMC samples (P≥ 0.05), a major decline (84%) was 
observed when the cells were incubated with Fe-pectin (P≤ 0.0001) and Fe-alginate 
(P≤ 0.0001), in which case there was 0% of cell survival. These results show that at 
50 mg/mL, Fe-pectin and Fe-alginate present a very strong toxic effect on HDNFs. 
Despite the statistical significance that was found in some cases by comparing each 
formulation used at 50 mg/mL with the control group, the same was not always verified 
for apparently different viability values, when multi-comparisons were performed using 
all the sample groups. The detailed results of a Tukey's multi-comparisons test 
performed to assess the differences between the samples at 50 mg/mL and the 
negative control can be consulted on Table S1. From 5 mg/mL and below, the viability 
of HNDFs, when compared to the control group, was not compromised by exposure 
to any of the extracts, (P≥0.05). These results show that the cytotoxic effects of Ga 
and Fe-based formulations are concentration dependent. Concentrations as high as 
50 mg/mL pose considerable limitations to cell survival and growth.  
There are several routes by which cell toxicity can be mediated, namely the 
catalysis of highly reactive oxygen radicals formation in iron mediated toxicity45, and 
enzymatic reactions that inhibit deoxyribonucleotide synthesis, partially responsible for 
the antineoplastic activity of gallium46. However, in this study, it is likely that the viability 
drops found using the highest concentration may have a strong contribution from the 
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rheological properties of the base polysaccharide used to develop the final 
formulations, other just than from Ga and Fe. At high concentrations, these materials 
form gels37, and in this case, caused the gelation of the culture media (see Figure S2). 
Gelation reduces the supply of nutrients and oxygen to the cells, leading to death, and 
that was particularly noticed on Na-CMC samples. Decreasing the concentration to 5 
mg/mL, not only reduced the amount of Ga and Fe available for cellular uptake, but 
also drastically decreased the viscosity of the culture media, resulting in a non toxic 
effect for all the tested formulations. Fe3+ ions are required for biological function, and 
usually considered as biocompatible, yet, when present at high levels, they can disrupt 
iron homeostasis and become cytotoxic47. On the other hand, Ga-based materials 
have now been exploited in many biomedical uses, including use as a tracer in nuclear 
medicine, as a treatment for various cancers48 and for non-Hodgkin’s lymphoma49. 
Therefore, materials capable to deliver Ga such as these demonstrated here should 
be considered for these therapies. As with most pharmacological agents, the safe 
applicability of these compounds will rest on the delicate balance between the 
concentration that is necessary to produce a therapeutic effect, and the toxic effects 
induced at that concentration. In the particular case of this study, given the obtained 
cytotoxicity profiles, the safe use of the developed compounds will rely on the minimum 
inhibitory (MIC) and minimum bactericidal concentrations (MBC) found for target 
bacteria. The results obtained here show that if MIC and MBC ≤ 5 mg/mL these 
compounds can be safely used as antimicrobial agents without inducing toxicity in 




Figure 4. Viability profiles of HNDFs after 24 h exposure to the extracts of test 
compounds. Results are averaged from triplicate samples of three independent 
replicates. Statistical significance was established using a One-way ANOVA test, 
followed by Tukey's multiple comparisons test. * indicates significant differences (P ≤ 
0.05), ** indicates very significant differences (P ≤ 0.01), *** (P ≤ 0.001) and **** P ≤ 
0.0001) represent extremely significant difference, when compared to the negative 
control.  
 




Results indicate that each test organism presents a unique susceptibility profile, when 
compared against compounds without the attached metal of interest (Table 2). In 
general, Na-CMC showed no observable degree of inhibition on bacterial growth even 
at a high concentration (> 10 mg/mL) while pectin and Na-alginate exhibited no effect 
on all three bacteria. Ga-CMC showed significant inhibitory effects on all three tested 
bacteria but Ga-alginate had no effect. Ga-pectin showed good inhibitory effect only 
on P. aeruginosa, but not on other test species. Among the Fe samples, both Fe-CMC 
and Fe-pectin showed some inhibitory effect on S. aureus growth but Fe-alginate had 
minimal demonstrable effect on all three bacteria. When compared among the three 
polysaccharide base materials, alginate samples showed the least inhibitory effect on 
all three bacteria.  This can be linked to the slowest degradation of the samples as 
tested in Section 3.3. Ga-CMC seemed to be the most promising candidate for 
developing as an antibacterial agent.   
 
Table 2. Minimum Inhibitory and Bactericidal Concentrations (MIC and MBC, 
respectively) for each of the test organisms, against the test metal compounds bound 
to polysaccharide, and the base polysaccharides as a control (X indicates no 




































 Na-CMC >10 >10 >10 >10 >10 >10 
Na-alginate X X X X X X 












 Ga-CMC 0.625 2.5 2.5 >10 1.25 2.5 
Ga-alginate X X X X X X 














 Fe-CMC 10 10 >10 10 2.5 >10 
Fe-alginate X X X X 10 10 
Fe-pectin 5 5 10 10 1.25 1.25 
 
These results, in combination with the viability study (Figure 4), indicate that 
Ga-CMC, Ga-pectin, and Fe-Pectin are very promising antimicrobial agents with no 
apparent toxicity to primary human dermal fibroblasts at MIC and MIB (≤ 5mg/mL) for 
P. aeruginosa. For S.aureus, the results were very similar, however, MBC using Fe-
CMC was >10 mg/mL, and this study cannot guarantee that concentration will be safe 
for human cells. Regarding E. coli, only the MIC for CMC was lower than 5 mg/mL. 
The viability study has shown that for sample concentrations ≥ 50 mg/mL a marked 
toxic effect is observed in HDNFs, and for concentrations ≤ 5 mg/mL no toxic effects 
are observed. However, there is one order of magnitude between these two values, 
and it would be useful to study a narrower concentration range, in order to obtain the 
LC50 and to investigate the safety of these compounds at 10 mg/mL. 
 
3.5 Action of Ga-CMC on bacteria in anaerobic conditions 
Because of the physiological relevance of oxygen levels, a separate experiment was 
carried out to investigate the effect of reduced oxygen level in atmosphere on the MIC 
of Ga-CMC. It was reported that the oxygen levels in infection usually are much lower 
than ambient atmosphere50. For example, it is about 5% O2 equivalent in perfused 
tissues while a near anaerobic condition is found in sites of inflammatory damage.  On 
balance, Ga-CMC is the most promising materials testing in the MIC/MBC assay. E. 
coli is facultatively anaerobic and is resilient in low O2 environment, hence it is an ideal 
model organism for this purpose. The wild-type E. coli strain P4 was used for this 
experiment as we have previously carried out thorough investigation of its sensitivities 
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to Ga as chloride and nitrate salts under aerobic and anaerobic conditions.51 The MIC 
for Ga-CMC under anaerobic conditions was found to be 10 mg/mL, compared with 
0.625 mg/mL in aerobic conditions. In a separate study on gallium salts (gallium nitrate 
and gallium citrate) with the same P4 strain carried out in our laboratory, similar results 
were also observed. Under aerobic conditions, the MIC values are 0.04 and 0.08 
mg/mL for nitrate and citrate respectively. Both MIC values elevated to 0.08 and 0.32 
mg/mL when the experiment was carried out in anaerobic conditions. Such an 
elevated MIC (up to x 20 times) is consistent with data reported for other Ga 
compounds on E coli (our data51 and data reported from literature52), as well as other 
bacterial species53,54. Under reduced oxygen levels, E coli substantially alters gene 
expression and metabolism. These adaptations are reflected in the higher 
concentration of antimicrobial agent that is required to inhibit its growth.  
 Although the gallium compounds evaluated in this study seem to have potential 
to be developed as bioresponsive antibacterial agents, which is in urgent need 
globally, further research is required to unfold the mystery of their interaction with 
bacterial cells, both in aerobic and anaerobic environment, and the key mechanisms 
in growth inhibitory. Another area of interest is the delivery and the controlled release 
of gallium. The use of polysaccharides allows gradual release of gallium, which is 
difficult to achieve using soluble compounds such as gallium nitrate and maltolate but 
use of other ligands should also be investigated. Biodegradable polymers such as 
polysaccharides can also deliver, or co-deliver, other antibacterial agents, hence 
widening their applications. Using these platforms for delivering positively charged 
antibacterial agents such as tobramycin, polymyxin B, colistin and nisin is an attractive 
prospect. In addition to antibacterial properties, gallium compounds have also shown 
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other medical uses including anticancer properties. This makes biomedical research 
on gallium compounds very attractive. 
The WHO have indicated that the proportion of E. coli and S. aureus reported 
as being resistant to commonly used agents is increasing. A key concern for E. coli is 
resistance to fluoroquinolones and third or later generation cephalosporins as well as 
carbapenems, whilst S. aureus resistance to beta-lactams is also of prime importance 
as these antibiotics are routinely used in human treatments55. Our data suggests that 
the bacteria responded to each sample in a species-specific manner. There is potential 
for these samples to be developed against specific target species, and therefore 
against specific infections. This could be an advantage when considering the need to 
deliver site- and species-specific therapy to a patient whilst minimising the potential 
for resistance to develop amongst co-existing flora. It also suggests that the growth 
response will be species dependant, and not simply effective against all Gram 
negative or Gram positive species.  
 
4. Conclusions 
Ga-CMC has demonstrated antibacterial activity against the three test bacterial 
species: E. coli, S. aureus, and P. aeruginosa, and revealed to be the most promising 
formulation among all tested samples. The data presented in this work indicate that 
these compounds present an attractive alternative for the development of antimicrobial 
actives, in a species-dependent manner, using polysaccharides to deliver an 
antibacterial activity.  Cytotoxicity work helps to further screen the suitability of each 
compound for clinical applications. By testing antibacterial active doses in a sensitive 
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cell marker, using commonly available in vitro assays, those that are tolerated by 
mammalian cells can be selected as candidates for future development.  
We also conducted a study on the enzymatic degradation kinetics of these 
metal loaded polysaccharide samples, which have the potential to be developed as 
bioresponsive delivery agents of gallium and other antibacterial metal species. Our 
new approach using anaerobic assay also examination of antibacterial activity under 
more realistic physiological conditions. The results in this investigation direct the 
conclusion to gallium loaded materials as the preferred material for further 
investigation as a mammalian cell-viable antibacterial agent. 
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